BFM
AVNS

Boothbay Fund Management’s Avanos Medical AVNS Stock Holding History

Boothbay Fund Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,920
Closed -$527K – 2065
2025
Q4 		$527K Buy
+46,920
New +$537K 0.01% 1112
2016
Q3 		– Sell
-7,474
Closed -$243K – 706
2016
Q2 		$243K Buy
+7,474
New +$229K 0.09% 312
2015
Q4 		– Sell
-9,224
Closed -$262K – 562
2015
Q3 		$262K Buy
+9,224
New +$322K 0.12% 232

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Boothbay Fund Management's AVNS Position: Q1 2026 in Review

Boothbay Fund Management sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 46,920 shares — an estimated $527K sold.

Boothbay Fund Management first reported a position in AVNS in Q3 2015 and held it in 3 quarters. The position peaked at $527K in Q4 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Boothbay Fund Management reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 46,920 Avanos Medical shares in Q1 2026, an estimated $527K.
  • Boothbay Fund Management first reported a position in Avanos Medical in Q3 2015 and held it in 3 quarters.
  • Boothbay Fund Management's Avanos Medical position peaked at $527K in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.